254 related articles for article (PubMed ID: 28049521)
21. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
22. NCoR controls glioblastoma tumor cell characteristics.
Heldring N; Nyman U; Lönnerberg P; Onnestam S; Herland A; Holmberg J; Hermanson O
Neuro Oncol; 2014 Jan; 16(2):241-9. PubMed ID: 24335696
[TBL] [Abstract][Full Text] [Related]
23. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
[TBL] [Abstract][Full Text] [Related]
24. SATB1 and bladder cancer: Is there a functional link?
Choudhary D; Clement JM; Choudhary S; Voznesensky O; Pilbeam CC; Woolbright BL; Taylor JA
Urol Oncol; 2018 Mar; 36(3):93.e13-93.e21. PubMed ID: 29079132
[TBL] [Abstract][Full Text] [Related]
25. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
26. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
27. Functional relevance of SATB1 in immune regulation and tumorigenesis.
Sunkara KP; Gupta G; Hansbro PM; Dua K; Bebawy M
Biomed Pharmacother; 2018 Aug; 104():87-93. PubMed ID: 29772444
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
29. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
30. SATB1 is a Novel Molecular Target for Cancer Therapy.
Ding M; Pan J; Guo Z; Liu Q; Yang C; Mao L
Cancer Invest; 2018 Jan; 36(1):28-36. PubMed ID: 29381393
[TBL] [Abstract][Full Text] [Related]
31. DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
Toda Y; Yoshimura R; Itahara M; Imai Y; Yamada K; Uno T; Nakata S; Hosogi S; Takata K; Ashihara E
Anticancer Res; 2019 Nov; 39(11):5983-5990. PubMed ID: 31704823
[TBL] [Abstract][Full Text] [Related]
32. Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.
Tesone AJ; Rutkowski MR; Brencicova E; Svoronos N; Perales-Puchalt A; Stephen TL; Allegrezza MJ; Payne KK; Nguyen JM; Wickramasinghe J; Tchou J; Borowsky ME; Rabinovich GA; Kossenkov AV; Conejo-Garcia JR
Cell Rep; 2016 Feb; 14(7):1774-1786. PubMed ID: 26876172
[TBL] [Abstract][Full Text] [Related]
33. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of SATB1 is associated with the development and progression of glioma.
Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
J Transl Med; 2012 Jul; 10():149. PubMed ID: 22839214
[TBL] [Abstract][Full Text] [Related]
35. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma.
Chen H; Shen X; Guo C; Zhu H; Zhou L; Zhu Y; Wang H; Zheng Y; Huang L
Cancer Biother Radiopharm; 2010 Dec; 25(6):713-21. PubMed ID: 21204766
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
37. SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes.
Yang Y; Wang Z; Sun L; Shao L; Yang N; Yu D; Zhang X; Han X; Sun Y
PLoS One; 2015; 10(9):e0139170. PubMed ID: 26422397
[TBL] [Abstract][Full Text] [Related]
38. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
39. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
40. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
